Company
ZOF -1.11%SBI Holdings Inc-Japan
Market Cap: €10.48 Billion
EUR as of Aug 2, 2026 | US$12.09 Billion
$ZOF -1.11% $ZOF Japan Financials Asset Management Japanese Financials Japanese Asset ManagementCompany Description
SBI Holdings Inc-Japan operates financial services, asset management, investment, cryptocurrency, and technology businesses, including securities brokerage, banking, insurance, investment funds, and venture capital.
SBI Holdings Inc-Japan Market Capitalization Over Time
View HistoryEvolution of SBI Holdings Inc-Japan market cap in the past 5 years
Market capitalizations are calculated from the opening stock price at the beginning of each month.
Top Competitors by Market Capitalization
Industry: Asset Management
| Company | Market Cap (USD) |
|---|---|
| BlackRock | $177.30 B |
| Blackstone | $159.00 B |
| BNY Mellon | $107.30 B |
| Brookfield | $94.91 B |
| KKR | $94.58 B |
Sector: Financials
| Company | Market Cap (USD) |
|---|---|
| Berkshire Hathaway | $1.103 T |
| JPMorgan | $935.13 B |
| Visa | $672.61 B |
| Mastercard | $506.38 B |
| Bank of America | $434.76 B |
Detailed Description
SBI Holdings, Inc. is a Japanese financial services and investment holding company known for its diversified and innovative business model. Founded in 1999 and headquartered in Tokyo, SBI Holdings has developed into a leading financial conglomerate, primarily operating through five major segments: Financial Services, Asset Management, Investment, Crypto-asset, and Next Generation Businesses. Its core activities span online securities brokerage, comprehensive banking operations, insurance solutions, and the management of investment trusts and private equity funds. SBI Holdings is recognized for pioneering the integration of Internet-based technologies into traditional finance, positioning itself as one of the world’s most distinctive and comprehensive financial groups. The company is influential in a range of sectors, including fintech, biotechnology, healthcare, and digital assets, reflecting its commitment to both financial innovation and advanced technology applications. SBI Holdings also invests in and incubates start-up companies with a focus on sectors such as IT, blockchain, and AI, and it has established a notable presence in the development and commercialization of pharmaceuticals and health foods based on 5-aminolevulinic acid (5-ALA). Through strategic alliances and global investments, SBI Holdings plays a significant role in shaping modern finance, digital transformation, and technological advancement in Asia and beyond.
Financials
| Last Financial Reports Date | March 31, 2026 |
| Revenue TTM | €10.15 B |
| EBITDA | €543.73 B |
| Gross Profit TTM | €5.62 B |
| Profit Margin | 22.54% |
| Operating Margin | -48.79% |
| Quarterly Revenue Growth | -5.40% |